Atlas Trials

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT00309985 · COMPLETED

Trial details

NCT number
NCT00309985
Sponsor
ECOG-ACRIN Cancer Research Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Hormone-sensitive Prostate Cancer
Start date
2006-09-26
Primary completion
2013-12-23
Enrollment
790

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.